Vitamin D Testing Market Size, Share, Opportunities, And Trends By Product (25-Hydroxy Vitamin D Testing, 1,25-Dihydroxy Vitamin D Testing, 24,25-Dihydroxy Vitamin D Testing), By Application (Clinical Testing, Research Testing), By Technique (Radioimmunoassay, ELISA, HPLC, LC-MS, Others), By Indication (Osteoporosis, Malabsorption, Vitamin D Deficiency, Others), And By Geography - Forecasts From 2023 To 2028

The vitamin D testing market is estimated to grow at a CAGR of 9.17% during the forecast period.

Vitamin D maintains healthy bones and teeth, prevents type I diabetes and cancer, and improves intestinal absorption of calcium, magnesium, and phosphate. The rising cases of vitamin D deficiency such as bone disease, diabetes, and certain cancers, and the adverse effects of its deficiency are boosting the vitamin D testing market size. Moreover, the product availability and easy access coupled with government and other institutions awareness programs is increasing the knowledge among people and it is expected to further bolster the vitamin D testing market demand.

Market Drivers

• Rising Prevalence of Osteoporosis and Other Bone-Disease

The higher prevalence rate of osteoporosis among people and other related bone diseases is widening the vitamin D testing market. Vitamin D helps maintain bone health and prevents bone diseases such as osteoporosis. According to the International Osteoporosis Foundation, one in three women and one in five men aged 50 years or above is prone to suffer osteoporosis fractures. Moreover, according to the National Osteoporosis Foundation, an estimated 8.9 million fractures are caused by osteoporosis per year. These figures suggest the risk of osteoporosis and thereby it is expected to widen the vitamin D testing market size during the forecast year.

• Several Adverse Health Effects Associated with Vitamin D Deficiency

Various adverse health effects happen because of vitamin D deficiency. The American Journal of Clinical Nutrition considers vitamin D deficiency a worldwide problem. The common serious disease with vitamin D deficiency is osteoporosis, dementia, depression, diabetes, and even cancer. According to the scientific review published in BMJ, vitamin D supplementation improves the immune system which helps in preventing cold and flu. Moreover, vitamin D deficiency may increase higher risk of hypertension, worsen asthma, especially in children, and develop an inflammatory disease such as inflammatory bowel disease, and lupus. The rising knowledge of these adverse effects and health consciousness among people is contemplated to propel the vitamin D testing market with more people getting their vitamin D levels tested.

• Changing Lifestyle Leading to Less Sunlight Exposure

People are moving towards a sedentary lifestyle which is leading to less exposure to sunlight causing vitamin D deficiency. Sunlight is the major source of vitamin D and with more heat waves, warm temperatures, and changing lifestyles, people are not getting enough sunlight exposure. According to a study conducted in Valencia, Spain, about 8 to 10 minutes of sunlight exposure at noon is enough to produce the recommended amount of vitamin D during the spring and summertime. Moreover, people with disabilities and older people aged 70 or above are less likely to go outdoors thereby having inefficient amounts of vitamin D as per UCLA Health Organization. Less exposure to sunlight causing vitamin D deficiency is expected to boost the vitamin D testing market with more people having a deficiency.

• Rising Government and Institutions Awareness Programs

People are less aware of vitamin D deficiency and most people don’t know the levels of vitamin D in their body. To encourage people to get the vitamin D test, the government and other institutions are initiating various awareness programs. For instance, Royal DSM India launched a campaign ‘Boost your ImmuniD’ in 2021 to address the that 80% of the Indian population has an insufficient amount of vitamin D level. The campaign was designed to educate the population about vitamin D benefits and importance. Moreover, the CRN Foundation announced the link between vitamin D and COVID-19 through Vitamin D & Me! education initiative suggesting more people increase their vitamin D level and get the vitamin D test. These initiatives raising knowledge and awareness among people are anticipated to boost the vitamin D testing market.

North America to witness notable growth during the forecast period

The North American region is expected to hold a significant share of the vitamin D testing market globally. The reasons attributed to such a significant share are rising osteoporosis cases among the population. According to International Osteoporosis Foundation, osteoporosis, and low bone density is the major health problem in the US especially for people aged 50 or above. Moreover, the technological advancements and research initiatives in the regions backed by government institutions are further expected to drive positively the vitamin D testing market in the region. For instance, the Centre for Disease Control and Prevention Vitamin D Standardization Certification Programme evaluates the accuracy and reliability of vitamin D tests and certifies those with accuracy and precision. These factors coupled with increased awareness among people about the vitamin D benefits are expected to account for a dominant share of the region in the vitamin D testing market.

Wider Range of Product Availability

The major key players and research studies are enhancing vitamin D testing solutions with more product availability. 25-hydroxy dominates the vitamin D testing market due to its ease of use and faster results. Additionally, calcidiol, 1,25-dihydroxy vitamin D, and calcitriol are other vitamin D tests in the vitamin D testing market. Certain companies such as Hurdle have launched home testing kits for vitamin D making it more accessible to general people. The wider availability of vitamin D testing among people is expected to encourage more people to get the vitamin D test thereby propelling the vitamin D testing market.

Major Market Players

• Abbott, a multinational healthcare company provides solutions in various healthcare ranges including vitamin D testing. It provides vitamin D testing through Abbott Architect 25-OH-vitamin D assay which is approved by FDA and it provides an automated solution.
• Siemens Healthineers AG focuses on stroke care with wider service solutions in non-communicable diseases, lung cancer, and others. Vitamin D Total Assay provides accurate vitamin D results and it is CDC certified vitamin D assay that defines pediatric expected values.

Market Developments

• In February 2023, Hurdle launched a vitamin D home test providing lab-quality results. This new test will be available under their Chronomics brand which will provide affordable tests from the comfort of home.
• In April 2022, Empower Clinics Inc. announced the launch of a Canada-approved vitamin D home testing kit by its subsidiary Medisure. It is the first Health Canada-approved solution for home which empowers the company’s vision of being a leading integrated healthcare company.
• In May 2021, Hologram Sciences launched its first direct-to-consumer brand named d.velop. The firm offers a diagnostic kit to test vitamin D levels before and two weeks after supplementation.

Vitamin D Testing Market Scope:

 

Report Metric	Details
Growth Rate	CAGR of 9.17% from 2021 to 2028
Base Year	2021
Forecast Period	2023 – 2028
Forecast Unit (Value)	USD Billion
Segments Covered	Product Application Technique Indication Geography
Regions Covered	North America, South America, Europe, Middle East and Africa, Asia Pacific
Companies Covered	Abbott F. Hoffmann-La Roche Ltd Siemens Healthineers AG Quest Diagnostics Incorporated. BIOMÉRIEUX
Customization Scope	Free report customization with purchase

 

Market Segmentation:

• By Product
  • 25-Hydroxy Vitamin D Testing
  • 1,25-Dihydroxy Vitamin D Testing
  • 24,25-Dihydroxy Vitamin D Testing
• By Application
  • Clinical Testing
  • Research Testing
• By Technique
  • Radioimmunoassay
  • ELISA
  • HPLC
  • LC-MS
  • Others
• By Indication
  • Osteoporosis
  • Malabsorption
  • Vitamin D Deficiency
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Indonesia
    • Thailand
    • Others

---

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definitions

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY  

2.1. Research Data

2.2. Research Process

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. The threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. VITAMIN D TESTING MARKET, BY PRODUCT

5.1. Introduction

5.2. 25-Hydroxy Vitamin D Testing

5.3. 1,25-Dihydroxy Vitamin D Testing

5.4. 24,25-Dihydroxy Vitamin D Testing

6. VITAMIN D TESTING MARKET, BY APPLICATION

6.1. Introduction

6.2. Clinical Testing

6.3. Research Testing

7. VITAMIN D TESTING MARKET, BY TECHNIQUE

7.1. Introduction

7.2. Radioimmunoassay

7.3. ELISA

7.4. HPLC

7.5. LC-MS

7.6. Others

8. VITAMIN D TESTING MARKET, BY INDICATION

8.1. Introduction

8.2. Osteoporosis

8.3. Malabsorption

8.4. Vitamin D Deficiency

8.5. Others

9. VITAMIN D TESTING MARKET, BY GEOGRAPHY

9.1. Introduction

9.2. North America

9.2.1. United States

9.2.2. Canada

9.2.3. Mexico

9.3. South America

9.3.1. Brazil

9.3.2. Argentina

9.3.3. Others

9.4. Europe

9.4.1. United Kingdom

9.4.2. Germany

9.4.3. France

9.4.4. Spain

9.4.5. Others

9.5. The Middle East and Africa

9.5.1. Saudi Arabia

9.5.2. UAE

9.5.3. Israel

9.5.4. Others

9.6. Asia Pacific

9.6.1. Japan

9.6.2. China

9.6.3. India

9.6.4. South Korea

9.6.5. Indonesia

9.6.6. Thailand

9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations

11. COMPANY PROFILES

11.1. Abbott

11.2. F. Hoffmann-La Roche Ltd

11.3. Siemens Healthineers AG

11.4. Quest Diagnostics Incorporated.

11.5. BIOMÉRIEUX

11.6. DiaSorin S.p.A.

11.7. Thermo Fisher Scientific Inc.

11.8. Beckman Coulter, Inc. (BD)

11.9. Tosoh Bioscience, Inc.

Abbott

F. Hoffmann-La Roche Ltd

Siemens Healthineers AG

Quest Diagnostics Incorporated.

BIOMÉRIEUX

DiaSorin S.p.A.

Thermo Fisher Scientific Inc.

Beckman Coulter, Inc. (BD)

Tosoh Bioscience, Inc.